CYTK
Price
$45.74
Change
-$1.25 (-2.66%)
Updated
Jan 17 closing price
Capitalization
5.4B
32 days until earnings call
PASG
Price
$0.60
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
37.06M
39 days until earnings call
Ad is loading...

CYTK vs PASG

Header iconCYTK vs PASG Comparison
Open Charts CYTK vs PASGBanner chart's image
Cytokinetics
Price$45.74
Change-$1.25 (-2.66%)
Volume$998.34K
Capitalization5.4B
Passage Bio
Price$0.60
Change-$0.00 (-0.00%)
Volume$230.13K
Capitalization37.06M
CYTK vs PASG Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. PASG commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and PASG is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CYTK: $45.74 vs. PASG: $0.60)
Brand notoriety: CYTK and PASG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 83% vs. PASG: 23%
Market capitalization -- CYTK: $5.4B vs. PASG: $37.06M
CYTK [@Biotechnology] is valued at $5.4B. PASG’s [@Biotechnology] market capitalization is $37.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whilePASG’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • PASG’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than PASG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 2 TA indicator(s) are bullish while PASG’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 2 bullish, 4 bearish.
  • PASG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PASG is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -1.89% price change this week, while PASG (@Biotechnology) price change was -10.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CYTK is expected to report earnings on May 07, 2025.

PASG is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.4B) has a higher market cap than PASG($37.1M). PASG YTD gains are higher at: 5.801 vs. CYTK (-2.764). PASG has higher annual earnings (EBITDA): -66.17M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. PASG (84.8M). PASG has less debt than CYTK: PASG (25.8M) vs CYTK (790M). CYTK has higher revenues than PASG: CYTK (3.22M) vs PASG (0).
CYTKPASGCYTK / PASG
Capitalization5.4B37.1M14,550%
EBITDA-481.94M-66.17M728%
Gain YTD-2.7645.801-48%
P/E RatioN/AN/A-
Revenue3.22M0-
Total Cash1.01B84.8M1,193%
Total Debt790M25.8M3,062%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKPASG
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
86%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
75%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 25 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOXQ41.811.17
+2.88%
Invesco PHLX Semiconductor ETF
AGRH26.010.11
+0.42%
iShares Interest Rt Hdg U.S. Aggt Bd ETF
ITB109.240.43
+0.40%
iShares US Home Construction ETF
IJUL27.960.06
+0.21%
Innovator Intl Dev Pwr Bffr ETF July
PUI40.560.07
+0.18%
Invesco Dorsey Wright Utilities Momt ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-2.66%
TRDA - CYTK
44%
Loosely correlated
+1.20%
KRON - CYTK
43%
Loosely correlated
-1.92%
DARE - CYTK
42%
Loosely correlated
+0.30%
CKPT - CYTK
41%
Loosely correlated
-4.50%
ACLX - CYTK
40%
Loosely correlated
-0.79%
More

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
N/A
AXON - PASG
43%
Loosely correlated
+1.37%
CYTK - PASG
38%
Loosely correlated
-2.66%
ARRY - PASG
35%
Loosely correlated
-0.14%
SNPX - PASG
32%
Poorly correlated
N/A
VYGR - PASG
31%
Poorly correlated
+0.20%
More